or Try an Advanced Search...

    Technical Analysis for PMVP - PMV Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    D 2.16 -0.92% -0.02
    PMVP closed down 0.92 percent on Wednesday, May 8, 2024, on 1.22 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical PMVP trend table...
    Date Alert Name Type % Chg
    New Uptrend Bullish 0.00%
    Doji - Bearish? Reversal 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Earnings Movers Other 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Pocket Pivot Bullish Swing Setup -0.92%
    Upper Bollinger Band Walk Strength -0.92%
    Older End-of-Day Signals for PMVP ...

       Recent Intraday Alerts

    Alert Time
    60 Minute Opening Range Breakdown about 16 hours ago
    Down 3% about 16 hours ago
    Down 2 % about 16 hours ago
    Down 1% about 16 hours ago
    Possible Pocket Pivot about 20 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    PMVP Chart by TradingView
    Basic chart:

    Profile

    PMV Pharma is a precision oncology company pioneering the discovery and development of small molecule, tumor-agnostic therapies targeting p53 mutations. p53 mutations are found in approximately half of all cancers. The field of p53 biology was established by our co-founder Dr. Arnold Levine when he discovered the p53 protein in 1979. Bringing together leaders in the field to utilize over four decades of p53 biology, PMV Pharma combines unique biological understanding with pharmaceutical development focus. PMV Pharma is headquartered in Cranbury, New Jersey.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Cancer Biology Cell Biology Proteins Apoptosis P53 Tumor Suppressor Genes

    Is PMVP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Apr 19 PMV Pharmaceuticals (NASDAQ:PMVP) Is In A Good Position To Deliver On Growth Plans
    Mar 27 PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
    Mar 18 PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women’s Cancer
    Mar 1 PMV Pharmaceuticals reports FY results
    Mar 1 PMV Pharmaceuticals Inc (PMVP) Reports Full Year 2023 Financial Results
    Feb 29 PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
    Feb 26 PMV Pharmaceuticals to Participate in the TD Cowen 44th Annual Health Care Conference
    Jan 18 PMV to focus on lead drug, slashes workforce by 30%
    Jan 18 PMV Pharmaceuticals Announces Prioritization of PC14586 Clinical Development and Extended Cash Runway
    Jan 5 PMV Pharmaceuticals names Michael Carulli as CFO
    See more PMVP news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 9.71
    52 Week Low 1.175
    Average Volume 602,794
    200-Day Moving Average 3.30
    50-Day Moving Average 1.74
    20-Day Moving Average 1.79
    10-Day Moving Average 1.92
    Average True Range 0.12
    RSI (14) 71.99
    ADX 26.99
    +DI 37.35
    -DI 9.89
    Chandelier Exit (Long, 3 ATRs) 1.89
    Chandelier Exit (Short, 3 ATRs) 1.85
    Upper Bollinger Bands 2.16
    Lower Bollinger Band 1.43
    Percent B (%b) 1.01
    BandWidth 40.41
    MACD Line 0.11
    MACD Signal Line 0.06
    MACD Histogram 0.053
    Fundamentals Value
    Market Cap 110.5 Million
    Num Shares 51.2 Million
    EPS -1.56
    Price-to-Earnings (P/E) Ratio -1.38
    Price-to-Sales 0.00
    Price-to-Book 0.36
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 2.37
    Resistance 3 (R3) 2.38 2.31 2.34
    Resistance 2 (R2) 2.31 2.26 2.31 2.32
    Resistance 1 (R1) 2.24 2.23 2.21 2.23 2.31
    Pivot Point 2.17 2.17 2.16 2.17 2.17
    Support 1 (S1) 2.10 2.12 2.07 2.09 2.01
    Support 2 (S2) 2.03 2.09 2.03 2.00
    Support 3 (S3) 1.96 2.03 1.99
    Support 4 (S4) 1.95